Resultados de procura - Fernando Velayos

  • Mostrando 1 - 18 Resultados de 18
Limitar resultados
  1. 1
    Pneumocystis carinii Pneumonia During Maintenance Anti–Tumor Necrosis Factor-α Therapy with Infliximab for Crohn’s Disease

    Pneumocystis carinii Pneumonia During Maintenance Anti–Tumor Necrosis Factor-α Therapy with Infliximab for Crohn’s Disease por Fernando Velayos, William J. Sandborn

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Systematic Review

    Systematic Review por Justin L. Sewell, Fernando Velayos

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Colorectal Cancer Screening and Surveillance in the Elderly: Updates and Controversies

    Colorectal Cancer Screening and Surveillance in the Elderly: Updates and Controversies por Lukejohn W. Day, Fernando Velayos

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Viral hepatitis and inflammatory bowel disease

    Viral hepatitis and inflammatory bowel disease por Jason K. Hou, Fernando Velayos, Norah A. Terrault, Uma Mahadevan

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Colonoscopy after CT Diagnosis of Diverticulitis to Exclude Colon Cancer: A Systematic Literature Review

    Colonoscopy after CT Diagnosis of Diverticulitis to Exclude Colon Cancer: A Systematic Literature Review por Victor F. Sai, Fernando Velayos, John Neuhaus, Antonio C. Westphalen

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab

    A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab por Fernando Velayos, James G. Kahn, William J. Sandborn, Brian G. Feagan

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Predictive and Protective Factors Associated With Colorectal Cancer in Ulcerative Colitis: A Case-Control Study

    Predictive and Protective Factors Associated With Colorectal Cancer in Ulcerative Colitis: A Case-Control Study por Fernando Velayos, Edward V. Loftus, Tine Jess, William S. Harmsen, John P. Bida, Alan R. Zinsmeister, William J. Tremaine, William J. Sandborn

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Prevalence of Colorectal Cancer Surveillance for Ulcerative Colitis in an Integrated Health Care Delivery System

    Prevalence of Colorectal Cancer Surveillance for Ulcerative Colitis in an Integrated Health Care Delivery System por Fernando Velayos, Liyan Liu, James D. Lewis, James E. Allison, Nicole Flowers, Susan Hutfless, Oren Abramson, Geraldine S. Perry, Lisa J. Herrinton

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications for Monitoring Recommendations

    Timing of Myelosuppression During Thiopurine Therapy for Inflammatory Bowel Disease: Implications for Monitoring Recommendations por James D. Lewis, Oren Abramson, M. Pascua, Liyan Liu, Laura Asakura, Fernando Velayos, Susan Hutfless, James E. Alison, Lisa J. Herrinton

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Time Trends in Therapies and Outcomes for Adult Inflammatory Bowel Disease, Northern California, 1998–2005

    Time Trends in Therapies and Outcomes for Adult Inflammatory Bowel Disease, Northern California, 1998–2005 por Lisa J. Herrinton, Liyan Liu, Bruce Fireman, James D. Lewis, James E. Allison, Nicole Flowers, Susan Hutfless, Fernando Velayos, Oren Abramson, Andrea Altschuler, Geraldine S. Perry

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis

    AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis por Siddharth Singh, Ashwin N. Ananthakrishnan, Nghia Nguyen, Benjamin L. Cohen, Fernando Velayos, Jennifer M. Weiss, Shahnaz Sultan, Shazia M. Siddique, Jeremy Adler, Karen A. Chachu

    Publicado 2023
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease

    AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease por Ashwin N. Ananthakrishnan, Jeremy Adler, Karen A. Chachu, Nghia Nguyen, Shazia M. Siddique, Jennifer M. Weiss, Shahnaz Sultan, Fernando Velayos, Benjamin L. Cohen, Siddharth Singh

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Risk of Intestinal Cancer in Inflammatory Bowel Disease: A Population-Based Study From Olmsted County, Minnesota

    Risk of Intestinal Cancer in Inflammatory Bowel Disease: A Population-Based Study From Olmsted County, Minnesota por Tine Jess, Edward V. Loftus, Fernando Velayos, William S. Harmsen, Alan R. Zinsmeister, Thomas C. Smyrk, Cathy D. Schleck, William J. Tremaine, L. Joseph Melton, Pia Munkholm, William J. Sandborn

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

    Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases por Konstantinos Papamichael, Adam S. Cheifetz, Gil Melmed, Peter M. Irving, Niels Vande Casteele, Patricia Kozuch, Laura E. Raffals, Leonard Baidoo, Brian Bressler, Shane Devlin, Jennifer Jones, Gilaad G. Kaplan, Miles Sparrow, Fernando Velayos, Thomas Ullman, Corey A. Siegel

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials

    Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials por Jennifer Jones, Gilaad G. Kaplan, Laurent Peyrin–Biroulet, Leonard Baidoo, Shane Devlin, Gil Melmed, Divine Tanyingoh, Laura E. Raffals, Peter M. Irving, Patricia Kozuch, Miles Sparrow, Fernando Velayos, Brian Bressler, Adam S. Cheifetz, Jean–Frédéric Colombel, Corey A. Siegel

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Appropriateness of Testing for Anti–Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

    Appropriateness of Testing for Anti–Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results por Gil Melmed, Peter M. Irving, Jennifer Jones, Gilaad G. Kaplan, Patricia Kozuch, Fernando Velayos, Leonard Baidoo, Miles Sparrow, Brian Bressler, Adam S. Cheifetz, Shane Devlin, Laura E. Raffals, Niels Vande Casteele, Diane R. Mould, Jean-Fred Colombel, Marla C. Dubinsky, William J. Sandborn, Corey A. Siegel

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

    SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease por Loren Laine, Tonya Kaltenbach, Alan Barkun, Kenneth R. McQuaid, Venkataraman Subramanian, Roy Soetikno, James E. East, Francis A. Farraye, Brian G. Feagan, John P. A. Ioannidis, Ralf Kießlich, Michael J. Krier, Takayuki Matsumoto, Robert P. McCabe, Klaus Mönkemüller, Robert D. Odze, Michael F. Picco, David T. Rubin, Michele Rubin, Carlos Rubio-Terrés, Matthew D. Rutter, Andrés Sánchez-Yagüe, Silvia Sanduleanu, Amandeep K. Shergill, Thomas Ullman, Fernando Velayos, Douglas Yakich, Yu–Xiao Yang

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease

    SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease por Loren Laine, Tonya Kaltenbach, Alan Barkun, Kenneth R. McQuaid, Venkataraman Subramanian, Roy Soetikno, James E. East, Francis A. Farraye, Brian G. Feagan, John P. A. Ioannidis, Ralf Kießlich, Michael J. Krier, Takayuki Matsumoto, Robert P. McCabe, Klaus Mönkemüller, Robert D. Odze, Michael F. Picco, David T. Rubin, Michele Rubin, Carlos Rubio-Terrés, Matthew D. Rutter, Andrés Sánchez-Yagüe, Silvia Sanduleanu, Amandeep K. Shergill, Thomas Ullman, Fernando Velayos, Douglas Yakich, Yu–Xiao Yang

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: